We are live on ! Find out more
CV

Clarus Ventures Portfolio holdings

AUM $425M
1-Year Est. Return 26.13%
This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+26.13%
3 Year Est. Return
+70.29%
5 Year Est. Return
+162.11%
10 Year Est. Return
–
AUM
$346M
AUM Growth
-$8.27M
Cap. Flow
-$30.3M
Cap. Flow %
-8.77%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$30.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$109M 31.53%
3,054,744
– –
NSTG
2
DELISTED
NanoString Technologies, Inc.
NSTG
$81.8M 23.66%
3,959,440
– –
AERI
3
DELISTED
Aerie Pharmaceuticals
AERI
$73.5M 21.27%
3,468,495
– –
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$51.8M 14.98%
2,579,062
– –
TLOG
5
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$29.6M 8.57%
4,644,705
– –
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
– –
-1,101,234
Closed -$30.3M

Similar funds

LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
SPC
Salient Private Client Houston, Texas $513M AUM 10.97% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
CG
Clinton Group New York $279M AUM 4.76% 1-Year Est. Return
AAM
Amerigo Asset Management George Town, Cayman Islands $254M AUM 115.73% 1-Year Est. Return
SE
Summit Equities Parsippany, New Jersey $601M AUM 9.74% 1-Year Est. Return
CA
Cynosure Advisors Salt Lake City, Utah $238M AUM 4% 1-Year Est. Return

Clarus Ventures's Q1 2014 Portfolio in Review

As of Q1 2014, Clarus Ventures held 6 positions worth $346M, down 2.3% from $354M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Clarus Ventures withdrew a net $30.3M in Q1 2014, closing 1 position. Its most notable exit was Zogenix, Inc., an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Clarus Ventures fully exited Zogenix, Inc. in Q1 2014, selling an estimated $30.3M.
  • Clarus Ventures's ten largest holdings make up 100% of its $346M portfolio in Q1 2014.
  • Clarus Ventures opened 0 new positions and closed 1 in Q1 2014.
  • Clarus Ventures's portfolio value fell 2.3% quarter-over-quarter to $346M.

Based on Clarus Ventures's 13F filing for Q1 2014, filed 9 May 2014.